药物发现信息性市场份额，规模，趋势，行业分析报告，由工作流程（发现信息学，发展信息学）;按模式（外包，内部）;通过服务（序列分析平台，分子建模，对接，临床试验数据管理，其他）;按地区;分部预测，2021 - 2028

报告摘要

The global drug discovery informatics market was valued at USD 2.42 billion in 2020 and is expected to grow at a CAGR of 11.4% during the forecast period. Key factors responsible for the market growth include advances in computing capabilities with rising adoption of AI and machine learning, increase in adoption of in-silico tools modeling tools, a huge volume of drug discovery data, and burgeoning demand for the new medicine or drugs.

了解有关此报告的更多信息：request for sample pages

此外，引入了新的数据发现平台，以加强市场的竞争。在这一条线上，在2021年1月，Certara推出了一种新版本的辛屏或PBPK）模拟器平台，以评估和分析哺乳期，怀孕和其他医疗病症的药物作用。

Furthermore, it helps users in deciding critical decisions with regard to drug safety and efficacy profile. Companies in the marketplace are continuously adopting computing capabilities dedicated to informatics to shorten long drug discovery process time.

2020年12月，Curve Therapeutics实施了CDD Vault平台来管理其转基编码的微循环平台。该平台适用于跨越无缝应用程序生物技术, drug discovery stakeholders, pharma, and academic institutions to share real-time data for collaborative discoveries.

Drug Discovery Informatics Market Report Scope

The market is primarily segmented on the basis of workflow, mode, services, and region.

通过工作流程	通过模式	通过服务	按地区
发现信息学 识别，验证和测定发展信息学 领先一代 开发信息学 Lead Optimization FHD准备 IA阶段 Phase IB/2	Outsourced 内部	Sequence Analysis Platforms 分子造型 Docking Clinical Trial Data Management Others	北美（美国，加拿大） 欧洲（法国，德国，英国，意大利，西班牙，荷兰，奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西，墨西哥，阿根廷） MEA（沙特阿拉伯，阿联酋，以色列，南非）

了解有关此报告的更多信息：request for sample pages

Insight by Workflow

4220年，发现信息学市场分部占最大的收入份额。这一高度份额主要是由于强烈关注精密药品的发展。它涉及基于其遗传和分子型材的特定患者护理。像PerkinElmer，Inc。这样的公司是通过利用市场快速药物发现信息学解决方案的分析来实现此类药物发现信息解决方案的重要员。

此外，全球若干政府正在迅速采用生物信息学，用于快速发现药物分子。在这条线上，印度政府于2020年7月推出了药物发现Hackathon（DDH）。这是培训模块，以促进对Covid-19的有效分子的发现，在药物发现工具中具有巨大应用，用于识别，设计和验证潜在的铅化合物。

药物开发市场部门预计将在研究期间见证利润丰厚的增长率。这主要是由于药品公司管道中的药物候选人数的增加。这些工具广泛用于执行临床试验所需的任务，以便为追踪性能提高和速度分析的改进。

通过模式洞察力

In 2020, the outsourced informatics market segment accounted for the largest share and is likely to register a steady market growth rate over the study period. This high share is attributed to rising partnerships between pharma companies and the contract research organizations involved in the development of new drug entities which are subsequently used by drug manufacturers for applying to the US. regulatory agency.

与Pharma和Biotech公司有几种优势，在与毒品信息学中具有重要专业知识的CROS合作。主机公司和CRO之间使用的共享信息性平台有助于监测研究进度。这也有助于公司节省成本并提高生产率收益，从而预计提供了一种丰盛的盈利市场机会。

The in-house market segment is projected to register a lucrative growth rate over the study period. This is due to the rising adoption of informatics solutions by large established pharmaceutical players across the globe. It offers, numerous advantages, such as direct access to information, lengthy data compilation.

Geographic Overview

地理上,全球药物发现备用ics market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). North America market is the largest revenue contributor followed by Europe and the Asia Pacific market.

In 2020, the North America drug discovery informatics market accounted for over 35.0% of the global market. This high share is attributed to few notable factors such as an increase in the incidence of infectious diseases, the presence of major market players, and the increasing need for advanced drug discovery tools to expedite the drug approval timeline.

Moreover, companies in the region are focusing on collaborations, and joint ventures to boost the region’s market growth. In this direction, in December 2020, Atomwise collaborated with vAirus, OrganAi, and A2i Therapeutics with several programs falling in the category of oncology, neuroscience, immunology, and clotting disorders.

竞争洞察力

在市场上运营的突出球员是Certiara，Infosys Ltd.，奥尔巴尼分子研究公司，查尔斯河实验室，Boehringer Ingelheim，合作药物发现，喜庆Biosys，Selvita，Novo信息学，Eurofins Discoverx产品，Chemazon Ltd.，Oracle，Oracle，Ercenture，Agilent Technologies，Inc。和Illumina，Inc。